According to the most recent financial data from March 2026, the current EPS (TTM) is $13.7. Idexx Laboratories's EPS for 2025 came in at $13.17, marking an increase from $10.77 in 2024. For the quarterly period ending on Mar 31, 2026, IDXX's EPS was $3.5.
Idexx Laboratories had an annual EPS of $13.17, marking an increase of 22.3% from $10.77 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $3.5, marking a 17.4% increase from the same quarter last year. IDXX's TTM EPS stands at $13.7 as of March 2026. Idexx Laboratories's EPS for 2024 stood at $10.77, a 5.9% increase from 2023.
Idexx Laboratories has recorded an increase in EPS of 17.4% over the last 12 months (YoY, quarterly). For the last three years, IDXX recorded an average annual EPS growth rate of 17.5%. Idexx Laboratories had an average annual EPS growth rate of 14.1% over the last 5 years. Across the last decade, IDXX had an average annual EPS growth of 20.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| HSIC Henry Schein Inc | 24.07 | 7.2% | -5.9% | 3.1% |
| ABT Abbott Laboratories | 25.28 | -51.4% | -1.8% | 8.2% |
| TMO Thermo Fisher Scientific Inc | 25.59 | 7.2% | 0% | 2% |
| IDXX Idexx Laboratories Inc | 39.49 | 22.3% | 17.5% | 14.1% |
| WOOF Petco Health & Wellness Company Inc | 126.75 | 108.1% | -55.5% | N/A |
| NEOG Neogen Corp | N/A | -12,475% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.